The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Long-term safety and efficacy of pomalidomide (POM) with or without low-dose dexamethasone (LoDEX) in relapsed and refractory multiple myeloma (RRMM) patients enrolled in the MM-002 phase II trial.
David Samuel DiCapua Siegel
Honoraria - Celgene; Merck; Millennium; Onyx
Paul Gerard Guy Richardson
Consultant or Advisory Role - Celgene; Johnson & Johnson; Millennium
Ravi Vij
Consultant or Advisory Role - Celgene; Onyx
Honoraria - Celgene; Millennium; Onyx
Research Funding - Celgene; Onyx
Craig C. Hofmeister
Consultant or Advisory Role - Celgene
Research Funding - Celgene; Merck; Millennium; Oncolytics Biotech
Rachid C. Baz
Research Funding - Bristol-Myers Squibb; Celgene; Millennium; Sanofi
Sundar Jagannath
Consultant or Advisory Role - Celgene; Merck Sharp & Dohme; Millennium; Onyx
Honoraria - Celgene; Merck Sharp & Dohme; Millennium; Onyx
Christine Chen
Honoraria - Celgene
Research Funding - Celgene
Sagar Lonial
Consultant or Advisory Role - Bristol-Myers Squibb; Celgene; Johnson & Johnson; Millennium; Novartis; Onyx; Sanofi
Andrzej J. Jakubowiak
Consultant or Advisory Role - Bristol-Myers Squibb; Celgene; Millennium; Onyx
Honoraria - Bristol-Myers Squibb; Celgene; Millennium; Onyx
Nizar J. Bahlis
Consultant or Advisory Role - Celgene
Honoraria - Celgene
Research Funding - Celgene
Kevin W. Song
Consultant or Advisory Role - Celgene; Janssen
Honoraria - Celgene; Janssen
Research Funding - Celgene; Janssen
Andrew Belch
No relevant relationships to disclose
Noopur S. Raje
Consultant or Advisory Role - Amgen; Celgene; Novartis
Research Funding - Acetylon Pharmaceuticals; AstraZeneca
Chaim Shustik
Consultant or Advisory Role - Celgene
Suzanne Lentzsch
Consultant or Advisory Role - Celgene
Research Funding - Celgene
Min Chen
Employment or Leadership Position - Celgene
Stock Ownership - Celgene
Mohamed H. Zaki
Employment or Leadership Position - Celgene
Stock Ownership - Celgene
Kenneth Carl Anderson
Consultant or Advisory Role - Bristol-Myers Squibb; Celgene; Millennium; Onyx
Other Remuneration - Acetylon Pharmaceuticals; OncoPep